Nickander, Jannike
Themudo, Raquel
Sigfridsson, Andreas
Xue, Hui
Kellman, Peter
Ugander, Martin
Article History
Received: 14 November 2019
Accepted: 2 June 2020
First Online: 25 June 2020
Competing interests
: J.N. has received minor speaker compensation from Orion Pharma A.B. and Sanofi Genzyme. P.K. receives research support (source codes) from Siemens Healthineers. M.U. is principal investigator on a clinical research and development agreement for CMR between Karolinska University Hospital and Siemens Healthineers. The remaining authors declare that they have no competing interests.